About Truepill
Truepill is a private company based in Hayward, California, incorporated in 2019 in Delaware. It has reported $307,491,954 raised in four offerings on Form D since December 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 16, 2023 | Sep 1, 2023 | $66,179,603of $107.0M target | 14 | $4.7M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 14, 2021 | Oct 29, 2021 | $142,476,323of $149.9M target | 9 | $15.8M | Equity, Series D Preferred StockRule 506(b) | Form D ↗ |
| Aug 26, 2020 | Sep 10, 2020 | $75,539,719of $76.0M target | 10 | $7.5M | EquityRule 506(b) | Form D ↗ |
| Dec 2, 2019 | Dec 17, 2019 | $23,296,309of $25.7M target | 6 | $3.8M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $307,491,954 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Truepill's Form D filed Sep 1, 2023.
Earlier filings also listed Siddarth Viswanathan (executive officer and director, last listed Oct 2021), Mohammad Afridi (chief executive officer and director, last listed Oct 2021), John Prince (director, last listed Oct 2021), Garry Tan (director, last listed Oct 2021), Ann Lamont (director, last listed Oct 2021), Alex Bangash (director, last listed Oct 2021) and Eric Woersching (director, last listed Dec 2019).